Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.20USD
4:00pm EDT
Change (% chg)

$0.02 (+9.50%)
Prev Close
$0.18
Open
$0.18
Day's High
$0.20
Day's Low
$0.18
Volume
89,015
Avg. Vol
163,796
52-wk High
$1.52
52-wk Low
$0.18

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $18.77
Shares Outstanding(Mil.): 104.84
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 103.50 32.14
EPS (TTM): -0.25 -- --
ROI: -69.16 1.52 12.66
ROE: -157.09 0.25 14.84

BRIEF-Regulus Reports Q1 Loss Per Share $0.15

* REGULUS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PIPELINE PROGRESS

May 10 2018

BRIEF-Kathryn Collier Joins Regulus Board Of Directors

* KATHRYN J. COLLIER JOINS REGULUS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Apr 17 2018

Competitors

Earnings vs. Estimates